["{\"step_by_step_thinking\": \"According to the documents, oral therapy is the most safe and economical method of correcting iron deficiency. Parenteral therapy should be confined to exceptional situations. Therefore, option D, which states that parenteral iron supplementation is required in a patient with Hb of less than 7 mg/dL, is not supported by the evidence.\n\nAdditionally, it's mentioned that oral iron therapy should be continued until the hemoglobin reaches a level considered normal for the individual, and there is no mention of stopping oral iron therapy once the patient achieves a hemoglobin of >12 mg/dL (option B).\n\nThe documents do suggest checking for allergy to iron preparation before infusion (option A), but this is not necessarily related to parenteral supplementation.\n\nIf gastric intolerance occurs with oral iron therapy, it's possible that some patients might require parenteral forms, but there is no general statement that all patients should be administered parenteral forms (option C).\", \"answer_choice\": C}"]